Estrella Debt To Assets from 2010 to 2026

ESLAW Stock   0.08  0.0009  1.20%   
Estrella Immunopharma Debt To Assets yearly trend continues to be fairly stable with very little volatility. Debt To Assets will likely drop to 0.04 in 2026. During the period from 2010 to 2026, Estrella Immunopharma Debt To Assets regression line of quarterly data had mean square error of  0.00000532 and geometric mean of  0.05. View All Fundamentals
 
Debt To Assets  
First Reported
2010-12-31
Previous Quarter
0.0449
Current Value
0.0399
Quarterly Volatility
0.00265157
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Estrella Immunopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Estrella Immunopharma's main balance sheet or income statement drivers, such as Tax Provision of 2 K, Selling General Administrative of 1.2 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 289. Estrella financial statements analysis is a perfect complement when working with Estrella Immunopharma Valuation or Volatility modules.
  
Build AI portfolio with Estrella Stock
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Estrella Stock Analysis

When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.